Investor Presentaiton

18 • Beyond the counter-cyclical nature of the healthcare industry in general, the Egyptian and other MENA markets are still highly-fragmented and underpenetrated. Favorable Industry Dynamics Highly-Fragmented and Underpenetrated Markets Operating in a still under-penetrated market IDH has a substantially larger footprint than its competitors, which are heavily concentrated in Cairo. A testament to the strength of its brands, IDH is able to sustain significantly higher pricing than its competitors in Egypt. Company IDH (combined) Alfa Labs Royal . Healthcare expenditures-per-capita and lab tests-per-capita demonstrate the underpenetrated nature of the IDH's markets. INTEGRATED DIAGNOSTICS HOLDINGS Egypt 2.5 Oman Lab tests per capita (2012) 23.2 9.6 10.1 Source: Analysis of the US Clinical Laboratory Market; Frost & Sullivan - March 2012 - NHS UK Total Egyptian points of presence Average price difference vs. Al Mokhtabar/Borg Total Healthcare Expenditures per Capita (2015) (2011 PPP* US$) 351 ■IDH North Africa GCC Average: 2,330 94 -11% 42 -33% Average: 721 2,273 2,320 2,405 Sudan 282 Average: 558 IDH's "Hub, Spoke and Spike" business model enables the Company to organically expand its reach in other highly-fragmented markets with underserved diagnostic services demand. *PPP: Purchasing power parity is based on the assumption that the exchange rate between two currencies is equal to the ratio of the currencies' respective purchasing power. ** USA, Japan, Russia, Italy, Germany, UK, France, Canada Source: World Health Organization Egypt 594 Jordan 798 Morocco 447 785 932 1,442 Qatar Saudi Arabia USA 2,466 Developed country average** 3,071 4,067

View entire presentation